MEKICS CO., Ltd (KOSDAQ:058110)
South Korea
· Delayed Price · Currency is KRW 1,670.00
+20.00 (1.21%)
At close: Mar 6, 2026
MEKICS CO., Revenue
MEKICS CO., had revenue of 2.78B KRW in the quarter ending September 30, 2025, with 68.65% growth. This brings the company's revenue in the last twelve months to 11.70B, up 3.15% year-over-year. In the year 2024, MEKICS CO., had annual revenue of 11.37B, down -14.27%.
Revenue (ttm)
11.70B
Revenue Growth
+3.15%
P/S Ratio
2.14
Revenue / Employee
169.51M
Employees
69
Market Cap
25.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.37B | -1.89B | -14.27% |
| Dec 31, 2023 | 13.26B | -15.49B | -53.88% |
| Dec 31, 2022 | 28.75B | -20.54B | -41.67% |
| Dec 31, 2021 | 49.30B | -18.76B | -27.56% |
| Dec 31, 2020 | 68.05B | 55.19B | 429.04% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RollingStone | 891.68M |
| Bistos | 19.37B |
| CU Medical Systems | 44.79B |
| Genesystem | 345.38M |
| UXN Co., Ltd. | 21.18M |
| Genoray | 102.75B |
| DRGEM | 98.34B |
| JPI Healthcare | 52.79B |